The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Immunomodulatory effects of Vitamin D in multiple sclerosis
Abstract
Although Vitamin D is best known as a modulator of calcium homeostasis, it also has immune modulating potential. A protective effect of Vitamin D on multiple sclerosis is supported by the reduced risk associated with sun exposure and use of Vitamin D supplements. Moreover, high circulating levels of Vitamin D have been associated with lower risk of multiple sclerosis. In this study, we measured 1,25 (OH)(2) Vitamin D and 25 (OH) Vitamin D levels in multiple sclerosis patients separated into different clinical subgroups according to disease status. In addition, direct effects of 1,25 (OH)(2) Vitamin D on ex vivo CD4+ T cells and myelin-peptide specific T cell lines were investigated to gain more insight into putative regulatory mechanisms in the disease pathogenesis. One hundred and thirty-two Hispanic patients with clinically definite multiple sclerosis were studied, 58 with relapsing remitting multiple sclerosis during remission, 34 during relapse and 40 primary progressive multiple sclerosis cases. Sixty healthy individuals matched with respect to place of residence, race/ethnicity, age and gender served as controls. Levels of 25(OH)D(3) and 1,25(OH)(2)D(3), measured by ELISA were significantly lower in relapsing-remitting patients than in controls. In addition, levels in patients suffering relapse were lower than during remissions. In contrast, primary progressive patients showed similar values to controls. Proliferation of both freshly isolated CD4+ T cells and MBP-specific T cells was significantly inhibited by 1,25(OH)(2)D(3). Moreover, activated Vitamin D enhanced the development of IL-10 producing cells, and reduced the number of IL-6 and IL-17 secreting cells. Notably, Vitamin D receptor expression was induced by 1,25(OH)(2)D(3) in both activated and resting cells. Interestingly, T cells were able to metabolize 25(OH)D(3) into biologically active 1,25(OH)(2)D(3), since T cells express alpha1-hydroxylase constitutively. Finally, 1,25(OH)(2)D(3) also increased the expression and biological activity of indoleamine 2,3-dioxygenase, mediating significant increase in the number of CD4+CD25+ T regulatory cells. Collectively, these data suggest that 1,25(OH)(2)D(3) plays an important role in T cell homeostasis during the course of multiple sclerosis, thus making correction of its deficiency may be useful during treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Prevention of Allogeneic Fetal Rejection by Tryptophan Catabolism
Munn, D. H., Zhou, M., Attwood, J. T., Bondarev, I., Conway, S. J., Marshall, B., Brown, C., & Mellor, A. L. (1998) · Science · doi:10.1126/science.281.5380.1191 · Cited by 2,585
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
Hyppönen, E., Läärä, E., Reunanen, A., Järvelin, M.-R., & Virtanen, S. M. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06580-1 · Cited by 1,928
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., & Ascherio, A. (2006) · JAMA · doi:10.1001/jama.296.23.2832 · Cited by 1,897
IL-17 family cytokines and the expanding diversity of effector T cell lineages
Weaver, C. T., Hatton, R. D., Mangan, P. R., & Harrington, L. E. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141557 · Cited by 1,842
Cortical demyelination and diffuse white matter injury in multiple sclerosis
Kutzelnigg, A., Lucchinetti, C. F., Stadelmann, C., Brück, W., Rauschka, H., Bergmann, M., Schmidbauer, M., Parisi, J. E., & Lassmann, H. (2005) · Brain · doi:10.1093/brain/awh641 · Cited by 1,836
Meisel, R., Zibert, A., Laryea, M., Göbel, U., Däubener, W., & Dilloo, D. (2004) · Blood · doi:10.1182/blood-2003-11-3909 · Cited by 1,646
Penna, G., & Adorini, L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2405 · Cited by 1,267
Barrat, F. J., Cua, D. J., Boonstra, A., Richards, D. F., Crain, C., Savelkoul, H. F., de Waal-Malefyt, R., Coffman, R. L., Hawrylowicz, C. M., & O'Garra, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011629 · Cited by 1,161
Modulatory Effects of 1,25-Dihydroxyvitamin D3 on Human B Cell Differentiation
Chen, S., Sims, G. P., Chen, X. X., Gu, Y. Y., Chen, S., & Lipsky, P. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.3.1634 · Cited by 1,119
Vitamin D intake and incidence of multiple sclerosis
Munger, K. L., Zhang, S. M., O’Reilly, E., Hernán, M. A., Olek, M. J., Willett, W. C., & Ascherio, A. (2004) · Neurology · doi:10.1212/01.wnl.0000101723.79681.38 · Cited by 1,093
Fallarino, F., Grohmann, U., You, S., McGrath, B. C., Cavener, D. R., Vacca, C., Orabona, C., Bianchi, R., Belladonna, M. L., Volpi, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.6752 · Cited by 1,047
Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-Dioxygenase
Munn, D. H., Sharma, M. D., Lee, J. R., Jhaver, K. G., Johnson, T. S., Keskin, D. B., Marshall, B., Chandler, P., Antonia, S. J., Burgess, R., et al. (2002) · Science · doi:10.1126/science.1073514 · Cited by 1,028
Multiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Merlino, L. A., Curtis, J., Mikuls, T. R., Cerhan, J. R., Criswell, L. A., & Saag, K. G. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11434 · Cited by 795
Cantorna, M. T., Hayes, C. E., & DeLuca, H. F. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7861 · Cited by 718
Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21141 · Cited by 714
Expression of 1,25-Dihydroxyvitamin D3 Receptor in the Immune System
Veldman, C. M., Cantorna, M. T., & DeLuca, H. F. (2000) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1605 · Cited by 710
D'Ambrosio, D., Cippitelli, M., Cocciolo, M. G., Mazzeo, D., Di Lucia, P., Lang, R., Sinigaglia, F., & Panina-Bordignon, P. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1050 · Cited by 652
Vitamin D Receptor: New Assignments for an Already Busy Receptor
Norman, A. W. (2006) · Endocrinology · doi:10.1210/en.2006-0946 · Cited by 582
Control of autoimmune diseases by the vitamin D endocrine system
Adorini, L., & Penna, G. (2008) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0855 · Cited by 557
Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study
van der Mei, I. A. F., Ponsonby, A.-L., Dwyer, T., Blizzard, L., Simmons, R., Taylor, B. V., Butzkueven, H., & Kilpatrick, T. (2003) · BMJ · doi:10.1136/bmj.327.7410.316 · Cited by 551
Lemire, J. M., & Archer, D. C. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115072 · Cited by 472
The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells
Mahon, B. D., Wittke, A., Weaver, V., & Cantorna, M. T. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10580 · Cited by 466
IDO and regulatory T cells: a role for reverse signalling and non-canonical NF-κB activation
Puccetti, P., & Grohmann, U. (2007) · Nature Reviews Immunology · doi:10.1038/nri2163 · Cited by 453
Hewison, M., Freeman, L., Hughes, S. V., Evans, K. N., Bland, R., Eliopoulos, A. G., Kilby, M. D., Moss, P. A. H., & Chakraverty, R. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5382 · Cited by 449
Simultaneous Measurement of Serum Tryptophan and Kynurenine by HPLC,
Widner, B., Werner, E. R., Schennach, H., Wachter, H., & Fuchs, D. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.12.2424 · Cited by 411
Alroy, I., Towers, T. L., & Freedman, L. P. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.10.5789 · Cited by 398
Curti, A., Pandolfi, S., Valzasina, B., Aluigi, M., Isidori, A., Ferri, E., Salvestrini, V., Bonanno, G., Rutella, S., Durelli, I., et al. (2007) · Blood · doi:10.1182/blood-2006-07-036863 · Cited by 396
Extra-renal 25-hydroxyvitamin D3-1α-hydroxylase in human health and disease
Hewison, M., Burke, F., Evans, K. N., Lammas, D. A., Sansom, D. M., Liu, P., Modlin, R. L., & Adams, J. S. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.078 · Cited by 394
Vitamin D as an immune modulator in multiple sclerosis, a review
Smolders, J., Damoiseaux, J., Menheere, P., & Hupperts, R. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.11.014 · Cited by 317
Acheson, E. D., Bachrach, C. A., & Wright, F. M. (1960) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1960.tb08674.x · Cited by 277
Identification and immune regulation of 25-hydroxyvitamin D-1-α-hydroxylase in murine macrophages
Overbergh, L., Decallonne, B., Valckx, D., Verstuyf, A., Depovere, J., Laureys, J., Rutgeerts, O., Saint-Arnaud, R., Bouillon, R., & Mathieu, C. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.2000.01204.x · Cited by 275
Cantorna, M. T., Woodward, W. D., Hayes, C. E., & DeLuca, H. F. (1998) · PubMed · Cited by 257
Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins
Islam, T., Gauderman, W. J., Cozen, W., & Mack, T. M. (2007) · Neurology · doi:10.1212/01.wnl.0000268266.50850.48 · Cited by 232
van der Mei, I. A. F., Ponsonby, A.-L., Blizzard, L., & Dwyer, T. (2001) · Neuroepidemiology · doi:10.1159/000054783 · Cited by 216
A Defect in Tryptophan Catabolism Impairs Tolerance in Nonobese Diabetic Mice
Grohmann, U., Fallarino, F., Bianchi, R., Orabona, C., Vacca, C., Fioretti, M. C., & Puccetti, P. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030633 · Cited by 210
Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., & Sharma, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.209 · Cited by 209
Spach, K. M., Nashold, F. E., Dittel, B. N., & Hayes, C. E. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.9.6030 · Cited by 206
Cantorna, M. T., Woodward, W. D., Hayes, C. E., & DeLuca, H. F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5314 · Cited by 205
Environmental risk factors in multiple sclerosis
Pugliatti, M., Harbo, H. F., Holmøy, T., Kampman, M. T., Myhr, K.-M., Riise, T., & Wolfson, C. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2008.01029.x · Cited by 187
Molecular Cloning of cDNA and Genomic DNA for Human 25-hydroxyvitamin D31α-hydroxylase
Monkawa, T., Yoshida, T., Wakino, S., Shinki, T., Anazawa, H., Deluca, H. F., Suda, T., Hayashi, M., & Saruta, T. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7508 · Cited by 185
Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., & Sharma, S. (1998) · PubMed · Cited by 179
ADORINI, L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06057.x · Cited by 175
van Halteren, A. G. S., Tysma, O. M. H., van Etten, E., Mathieu, C., & Roep, B. O. (2004) · Journal of Autoimmunity · doi:10.1016/j.jaut.2004.06.004 · Cited by 156
Pedersen, L. B., Nashold, F. E., Spach, K. M., & Hayes, C. E. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21382 · Cited by 150
Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases
Adorini, L. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00049-8 · Cited by 149
Penna, G., Amuchastegui, S., Cossetti, C., Aquilano, F., Mariani, R., Sanvito, F., Doglioni, C., & Adorini, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8504 · Cited by 135
Muthian, G., Raikwar, H. P., Rajasingh, J., & Bright, J. J. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20826 · Cited by 134
Receptors for 1α,25(OH)2D3: Past, Present, and Future
Norman, A. W. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.9.1360 · Cited by 123
Nashold, F. E., Hoag, K. A., Goverman, J. M., & Hayes, C. E. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(01)00360-5 · Cited by 117
Meehan, T. F., & DeLuca, H. F. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00580-5 · Cited by 111
Dong, X., Lutz, W. H., Schroeder, T. M., Bachman, L. A., Westendorf, J. J., Kumar, R., & Griffin, M. D. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506516102 · Cited by 94
Munker, R., Kobayashi, T., Elstner, E., Norman, A. W., Uskoković, M. R., Zhang, W., Andreeff, M., & Koeffler, H. (1996) · Blood · doi:10.1182/blood.v88.6.2201.bloodjournal8862201 · Cited by 79
Overbergh, L., Stoffels, K., Waer, M., Verstuyf, A., Bouillon, R., & Mathieu, C. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0678 · Cited by 78
Bartels, L. E., Jørgensen, S. P., Agnholt, J. S., Kelsen, J., Hvas, C. L., & Dahlerup, J. F. (2007) · International Immunopharmacology · doi:10.1016/j.intimp.2007.09.016 · Cited by 74
Correale, J. D., McMillan, M., McCarthy, K. A., Le, T. D., & Weiner, L. P. (1995) · Neurology · doi:10.1212/wnl.45.7.1370 · Cited by 74
Self-citationEarly Events of TCR Signaling Are Distinct in Human Th1 and Th2 Cells
Hannier, S., Bitegye, C., & Demotz, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.4.1904 · Cited by 22
Monocyte-derived dendritic cells in multiple sclerosis: The effect of bacterial infection
Correale, J. D., & Farez, M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.08.011 · Cited by 22
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Cited by
Vitamin D and the immune system
Aranow, C. (2011) · Journal of Investigative Medicine · doi:10.2310/jim.0b013e31821b8755 · Cited by 1,436
Vitamin D: modulator of the immune system
Baeke, F., Takiishi, T., Korf, H., Gysemans, C., & Mathieu, C. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.04.001 · Cited by 1,300
Vitamin D and multiple sclerosis
Ascherio, A., Munger, K. L., & Simon, K. C. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70086-7 · Cited by 576
Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity
Kamen, D. L., & Tangpricha, V. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0590-9 · Cited by 560
Joshi, S., Pantalena, L.-C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., Ichiyama, K., Yoshimura, A., Steinman, L., Christakos, S., et al. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05020-11 · Cited by 458
Metadata
- Authors
- Correale, J., Ysrraelit, M. C., & Gaitan, M. I.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-03-24
- Volume
- 132
- Issue
- 5
- Pages
- 1146-1160
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2034742236
- Cited by
- 538
- References
- 64
- FWCI
- 36.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.